AstraZeneca's Wainua failure hurts credibility more than valuation, Jefferies warns

AstraZeneca's Wainua failure hurts credibility more than valuation, Jefferies warns

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.